ENTECAVIR ANHYDROUS

7098 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ENTECAVIR ANHYDROUS:

# Side effect Count
0 OFF LABEL USE 429
1 DRUG INEFFECTIVE 362
2 DRUG RESISTANCE 357
3 DEATH 295
4 PYREXIA 259
5 DIARRHOEA 256
6 HEPATITIS B 254
7 FATIGUE 225
8 PLATELET COUNT DECREASED 220
9 PNEUMONIA 217
See all common reactions for ENTECAVIR ANHYDROUS

ENTECAVIR ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENOTYPE DRUG RESISTANCE TEST 30 0.6122
1 HEPATITIS B DNA INCREASED 87 0.1291
2 HEPATITIS B REACTIVATION 152 0.0478
3 GENOTYPE DRUG RESISTANCE TEST POSITIVE 45 0.0438
4 HEPATITIS B 254 0.0421
5 OSTEOMALACIA 58 0.0375
6 VIRAL MUTATION IDENTIFIED 130 0.0353
7 FANCONI SYNDROME ACQUIRED 49 0.0279
8 FANCONI SYNDROME 36 0.0254
9 VIRAL LOAD INCREASED 89 0.0229
See all enriched reactions for ENTECAVIR ANHYDROUS